Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Conference Correspondent
ACR 2017
ASCO 2017 - Acute Myeloid Leukemia
ASCO 2017 - Chronic Lymphocytic Leukemia
ASCO 2019 - Chronic Lymphocytic Leukemia
ASCO 2020 - Lung Cancer
ASCO 2021 - GU Highlights
ASH 2016 - Chronic Lymphocytic Leukemia
ASH 2016 - Multiple Myeloma
ASH 2017 - Chronic Lymphocytic Leukemia
ASH 2018 - Chronic Lymphocytic Leukemia
ASH 2019 - Chronic Lymphocytic Leukemia
Conference Highlights ADA
Conference Highlights AHA
Conference Highlights AMCP
Conference Highlights ASCO
Conference Highlights ASH
Conference Highlights Digestive Disease Week
Conference Highlights ISPOR
Conference Highlights NCCN
Conference Highlights SABCS
IDWeek 2018
Conference Correspondent
,
ASH 2016 - Chronic Lymphocytic Leukemia
11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies
Play Video
Conference Correspondent
,
ASH 2016 - Chronic Lymphocytic Leukemia
5-Year Ibrutinib Therapy in Treatment-Naïve Patients with Relapsed or Refractory CLL or SLL
Play Video
Conference Correspondent
A Diagnostic Test for Lupus Based on DNA Methylation Signatures from Peripheral Blood Mononuclear Cells
Play Video
ASCO 2017 - Chronic Lymphocytic Leukemia
,
Conference Correspondent
A Genetic Risk-Stratified Phase 2 Study of Fludarabine/Antibody Combinations in Symptomatic, Untreated CLL: Results from Cancer and Leukemia Group B (CALGB) 10404 (Alliance)
Play Video
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
A New Risk Stratification Tool to Estimate Survival in Patients with Multiple Myeloma After First Relapse
Play Video
ACR 2017
,
Conference Correspondent
Active Treatment Leads to Improved Myocardial Function in Patients with Active RA
Play Video
Conference Correspondent
Adding Abatacept to the Euro-Lupus Nepthritis Regimen in Patients with Lupus Nephritis: Results from ACCESS, a 24-Week, Double-Blind Controlled Trial
Play Video
ACR 2017
,
Conference Correspondent
An Updated Integrated Safety Analysis of Baricitinib for the Treatment of Moderate-to-Severe RA
Play Video
Conference Correspondent
Association of Psoriasis and Psoriatic Arthritis with Lupus
Play Video
Conference Correspondent
AVBCC Sixth Annual Conference: The Evolution of Value-Based Cancer Care
Wayne Kuznar
Play Video
1
2
3
4
Page 1 of 8
Results 1 - 10 of 80